ERBB2 and inflammatory breast carcinoma: To investigate the functional role of DCN in IBC, we first generated stable DCN overexpression in four IBC cell lines [ER−/PR−/HER2+: MDA-IBC339, and SUM190; ER−/PR−/HER2−: SUM149 and BCX01040].